TINA CARDEN: Open Payments
NPI 1215490230 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 14 payments from 9 companies in 2025. Trend: 2023 $326 · 2024 $101 · 2025 $475
Food & beverage: $391Education: $84
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. | 1 | $129 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $84 |
| ABBVIE INC. | 3 | $54 |
| Rigel Pharmaceuticals, Inc. | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $25 |
| TAIHO ONCOLOGY, INC. | 1 | $23 |
| SERVIER PHARMACEUTICALS LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Optune Lua (NovoTTF-200T), SARCLISA, SCEMBLIX, TAVALISSE, KISQALI, Trodelvy, VENCLEXTA, LONSURF.
Industry payments across TN — which companies pay providers there.
